Functional roles of CSPG4/NG2 in chondrosarcoma |
| |
Authors: | Nuor S. M. Jamil Asim Azfer Harrison Worrell Donald M. Salter |
| |
Affiliation: | Centre for Genomic and Experimental Medicine, MRC IGMM, University of Edinburgh, Edinburgh, UK |
| |
Abstract: | CSPG4/NG2 is a multifunctional transmembrane protein with limited distribution in adult tissues including articular cartilage. The purpose of this study was to investigate the possible roles of CSPG4/NG2 in chondrosarcomas and to establish whether this molecule may have potential for targeted therapy. Stable knock‐down of CSPG4/NG2 in the JJ012 chondrosarcoma cell line by shRNA resulted in decreased cell proliferation and migration as well as a decrease in gene expression of the MMP (matrix metalloproteinase) 3 protease and ADAMTS4 (aggrecanase). Chondrosarcoma cells in which CSPG4/NG2 was knocked down were more sensitive to doxorubicin than wild‐type cells. The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy and that anti‐CSPG4/NG2 therapies may have potential in the treatment of surgically unresectable chondrosarcoma. |
| |
Keywords: | chondrosarcoma CSPG4 NG2 therapy |
|